Corvus Pharmaceuticals CRVS Earnings Call Transcripts

NASDAQ CRVS
$11.35 +0.81 (+7.69%)
At close: Nov 9, 2026 · 4:00 PM EST
2 earnings calls on file for Corvus Pharmaceuticals, from Q4 2025 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Corvus Pharmaceuticals Q2 2026 Earnings Call

Aug 6, 2026 5,357 words · 23 min read
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Corvus Pharmaceuticals Earnings Call Transcripts

Calls2
LatestAug 6, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 2 Corvus Pharmaceuticals transcripts Register to get access to Corvus Pharmaceuticals’s earnings call transcripts.